Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
about
Plasma biomarkers discriminate clinical forms of multiple sclerosisRole of platelets in neuroinflammation: a wide-angle perspectiveCXCR3 blockade inhibits T-cell migration into the CNS during EAE and prevents development of adoptively transferred, but not actively induced, diseaseMacrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation.Oriental Medicine Samhwangsasim-tang Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Th1 Cell Responses and Upregulating Treg Cell Responses.Vibrio vulnificus MO6-24/O lipopolysaccharide stimulates superoxide anion, thromboxane B₂, matrix metalloproteinase-9, cytokine and chemokine release by rat brain microglia in vitro.Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cordMarkedly increased IP-10 production by blood-brain barrier in neuromyelitis opticaDimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK PathwayFamily Analysis of Linkage and Association of HLA-DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9 and TIMP1 Gene Polymorphisms with Multiple SclerosisInflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelinationSubcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous SystemDecreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis.Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.Neurodegeneration induced by PVC-211 murine leukemia virus is associated with increased levels of vascular endothelial growth factor and macrophage inflammatory protein 1 alpha and is inhibited by blocking activation of microgliaThe inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adrenoleukodystrophy)PPAR Regulation of Inflammatory Signaling in CNS Diseases.Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.Current status and challenges of cytokine pharmacology.Chemokines and chemokine receptors in multiple sclerosis.HIV-1 Nef induces CCL5 production in astrocytes through p38-MAPK and PI3K/Akt pathway and utilizes NF-kB, CEBP and AP-1 transcription factors.The blood-brain barrier, chemokines and multiple sclerosisSex steroids control neuroinflammatory processes in the brain: relevance for acute ischaemia and degenerative demyelination.Is the CCR5 Δ 32 mutation associated with immune system-related diseases?Regulation of claudins in blood-tissue barriers under physiological and pathological statesInhibition of lipopolysaccharide-induced microglia activation by calcitonin gene related peptide and adrenomedullin.CXCR3 plays a critical role for host protection against Salmonellosis.Predictors of tumor-infiltrating lymphocyte efficacy in melanoma.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation.IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells.Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis.Host immune response to tuberculous meningitis.Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.
P2860
Q28262774-E26E1596-AF4F-4B89-882A-72713D3F796CQ28393808-9B97BA89-49FD-4208-91F9-7353D40C1AE8Q28578270-F600E66B-89E6-4414-96CA-2483FB598AE2Q30573013-C63F7550-6A85-4724-BDC5-65C771151122Q33571722-B4675ACB-3796-474A-9B23-025EC8E06F67Q33575716-5AEABA55-18E5-4047-B897-C7CA1C171AAAQ35156771-6937E863-4103-468E-8458-4BC293C5A816Q35219651-0D3A0C9D-0B9E-4906-9A68-BC7B95ACC4C0Q35814106-08EB80B9-9BB5-46A1-AA8E-5001155CC929Q35944470-BCCEB5C6-5ACB-4430-8924-31B402E53DADQ36147149-78EA673A-1F8F-4ABE-A9ED-D1F52F418005Q36362639-CD266D4B-EDFC-42E7-A7D8-09F51B9496E9Q36482109-87ADCE36-39DB-4E69-A4C9-E4208D350F8BQ36607157-9AB28C71-C262-48E1-A564-A81F0512DB23Q36639036-3C2223B1-9481-4A64-9E88-513B0268DD0DQ37192113-15D9093C-F11A-49A8-A5F9-2E9E4E822F7BQ37217534-83C806E9-EC1C-4776-A03E-FA59A0FCDF18Q37231755-BB908084-8D40-4C33-A5F8-64840B06E620Q37367956-B6F56A96-467E-4394-9306-3DFB5F05F024Q37445966-CC670F02-772D-4F51-9BB0-A90630EAA024Q37594837-BA555962-CA4C-4893-A850-1289B4F62EBFQ37657314-C38CE5F2-5C4A-48B1-85D2-99E00D6C9098Q37778548-5E6E635C-F8D7-4923-BA68-1352683D10ADQ37876955-4062DB66-CE8C-4F46-9AFC-D6039DA7AB89Q38068379-A4A77AAD-4404-4366-AD0E-1CCADD216A39Q38199105-1D365383-B8EE-4E8E-9649-A169567EA9F4Q38465366-E699B9C7-A698-4251-98F4-10E1BE328612Q38599089-7022B7E0-0B28-4BF0-ACAF-D5586DF6FB0AQ38665128-6833327F-E452-46D7-9A41-0645EFD44603Q38774697-451D6C03-FB98-42EA-8D47-FBAC1C7C1EDDQ38984981-BD7673EB-0585-47E7-8FFE-3E80740D9732Q39657367-D46B12E9-D38C-4751-B61E-94A225C7421CQ39710406-381216C1-3C56-4F93-BA90-02DAD67FACDDQ39732235-FD7DC7C0-0FF6-44CF-9D3D-E0CB939190F8Q41126508-2BAFEAD5-CB60-407F-9C29-A4D9ABA03486Q41359654-28B94875-AE2E-4A8C-8AED-35759A341470Q41471364-4F280494-A537-412D-85F9-E5B92AD38426Q41589802-79917D73-2EF8-40E3-A8C8-83966726523AQ41707503-82398C26-DF0D-462A-AC0D-ED0B6676FBF1Q41789029-3000DB04-3A8B-471B-8E9E-429E7EDD27F9
P2860
Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemokines and chemokine recep ...... ial targets for new therapies.
@ast
Chemokines and chemokine recep ...... ial targets for new therapies.
@en
type
label
Chemokines and chemokine recep ...... ial targets for new therapies.
@ast
Chemokines and chemokine recep ...... ial targets for new therapies.
@en
prefLabel
Chemokines and chemokine recep ...... ial targets for new therapies.
@ast
Chemokines and chemokine recep ...... ial targets for new therapies.
@en
P2860
P1476
Chemokines and chemokine recep ...... ial targets for new therapies.
@en
P2093
Adam Szczuciński
Jacek Losy
P2860
P304
P356
10.1111/J.1600-0404.2006.00749.X
P407
P577
2007-03-01T00:00:00Z